Evaluation of saliva as a specimen for monitoring zidovudine therapy in HIV‐infected patients
作者:
Boris Rolinski,
Uwe Wintergerst,
Alexander Matuschke,
Hermann Füessl,
Frank Goebel,
Adelbert Roscher,
Bernd Belohradsky,
期刊:
AIDS
(OVID Available online 1991)
卷期:
Volume 5,
issue 7
页码: 885-888
ISSN:0269-9370
年代: 1991
出版商: OVID
关键词: Zidovudine;drug monitoring;pharmacokinetics;saliva;HIV.
数据来源: OVID
摘要:
To facilitate studies of the pharmacokinetic properties of zidovudine, the relationship between plasma and salivary concentrations of the drug was studied, after oral dosage, in 10 HIV-infected patients. Zidovudine concentrations were determined in plasma, unstimulated mixed saliva and citric-acid-stimulated mixed saliva over a period of 3± hours by high-performance liquid chromatography. Correlation coefficients were r = 0.97 (P < 0.0001) for stimulated saliva compared with plasma and r = 0.89 (P < 0.0001) for unstimulated saliva, with average values in unstimulated saliva being 113.8 ± 44.6% in plasma and 67.8 ± 25.4% in stimulated saliva. Stimulated saliva values found to be 70% of the total reflected the concentration of the unbound drug in plasma. Except for a shorter half-life time (t) in saliva, pharmacokinetic parameters showed a good correlation in the three types of specimen. These findings and the convenience of sample collection suggest that citric-acid-stimulated saliva might be an appropriate specimen for monitoring zidovudine therapy.
点击下载:
PDF
(324KB)
返 回